Total Payments
$19,661
2024 Payments
$2,254
Companies
66
Transactions
950
Medicare Patients
2,507
Medicare Billing
$179,925
Payment Breakdown by Category
Food & Beverage$18,428 (93.7%)
Consulting$1,200 (6.1%)
Education$32.89 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,428 | 943 | 93.7% |
| Consulting Fee | $1,200 | 1 | 6.1% |
| Education | $32.89 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,898 | 78 | $0 (2024) |
| Lilly USA, LLC | $1,572 | 96 | $0 (2024) |
| ABBVIE INC. | $1,460 | 74 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,264 | 60 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,227 | 2 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $1,227 | 69 | $0 (2024) |
| PFIZER INC. | $891.32 | 68 | $0 (2023) |
| GlaxoSmithKline, LLC. | $808.66 | 34 | $0 (2024) |
| Amgen Inc. | $793.95 | 27 | $0 (2024) |
| Allergan, Inc. | $733.76 | 68 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,254 | 100 | ABBVIE INC. ($480.32) |
| 2023 | $1,720 | 87 | ABBVIE INC. ($243.85) |
| 2022 | $1,641 | 83 | SANOFI-AVENTIS U.S. LLC ($193.25) |
| 2021 | $3,692 | 128 | Biohaven Pharmaceuticals, Inc. ($1,227) |
| 2020 | $2,157 | 132 | Allergan, Inc. ($275.81) |
| 2019 | $2,429 | 124 | Novo Nordisk Inc ($423.13) |
| 2018 | $2,816 | 136 | AstraZeneca Pharmaceuticals LP ($282.39) |
| 2017 | $2,952 | 160 | Novo Nordisk Inc ($424.10) |
All Payment Transactions
950 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Vaccines | ||||||
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Respiratory | ||||||
| 11/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Oncology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Obesity | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: ADHD | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 457 | 660 | $100,725 | $34,322 |
| 2022 | 11 | 553 | 851 | $125,854 | $44,445 |
| 2021 | 13 | 748 | 1,146 | $142,938 | $55,541 |
| 2020 | 14 | 749 | 1,109 | $107,552 | $45,617 |
Total Patients
2,507
Total Services
3,766
Medicare Billing
$179,925
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 175 | $43,750 | $12,284 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 204 | $35,700 | $10,633 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $8,319 | $7,629 | 91.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 19 | $5,700 | $2,091 | 36.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 16 | 16 | $1,200 | $648.80 | 54.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 77 | 82 | $1,148 | $279.62 | 24.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 38 | $2,508 | $271.25 | 10.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 26 | $1,560 | $243.58 | 15.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 17 | $340.00 | $142.80 | 42.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 20 | $500.00 | $99.12 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 232 | $58,000 | $17,936 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 200 | $35,000 | $10,757 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 62 | 62 | $10,396 | $7,673 | 73.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 37 | $11,295 | $3,803 | 33.7% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 19 | 19 | $1,510 | $1,230 | 81.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 19 | 26 | $1,860 | $1,066 | 57.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $770.00 | $647.70 | 84.1% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 21 | 33 | $2,115 | $523.58 | 24.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 80 | 114 | $2,280 | $337.77 | 14.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 74 | 84 | $1,176 | $288.62 | 24.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 22 | $1,452 | $182.01 | 12.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 126 | 313 | $48,675 | $17,020 | 35.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 195 | $43,110 | $16,156 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 76 | 76 | $15,124 | $9,609 | 63.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 40 | 49 | $14,700 | $5,017 | 34.1% |
About Dr. Mark Glodener, MD
Dr. Mark Glodener, MD is a Family Medicine healthcare provider based in Alpharetta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174629885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Glodener, MD has received a total of $19,661 in payments from pharmaceutical and medical device companies, with $2,254 received in 2024. These payments were reported across 950 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($18,428).
As a Medicare-enrolled provider, Glodener has provided services to 2,507 Medicare beneficiaries, totaling 3,766 services with total Medicare billing of $179,925. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Alpharetta, GA
- Active Since 09/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174629885
Products in Payments
- NURTEC ODT (Drug) $1,268
- FARXIGA (Drug) $649.54
- QULIPTA (Drug) $645.34
- TRULICITY (Drug) $594.89
- Ozempic (Drug) $578.39
- SOLIQUA 100/33 (Biological) $577.76
- Vascepa (Drug) $555.24
- TRINTELLIX (Drug) $523.59
- Livalo (Drug) $487.98
- Tresiba (Drug) $426.16
- MOUNJARO (Drug) $414.84
- UBRELVY (Drug) $407.79
- AJOVY (Drug) $404.38
- CHANTIX (Drug) $394.14
- TRELEGY ELLIPTA (Drug) $301.52
- JARDIANCE (Drug) $300.54
- Trulance (Drug) $293.84
- Synthroid (Drug) $286.23
- QELBREE (Drug) $278.30
- AFREZZA (Drug) $275.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Alpharetta
Richard Shack, Md, MD
Family Medicine — Payments: $15,635
Family Medicine $15,635
Mrs. Arielle Sullivan-Harris, M.d, M.D
Family Medicine — Payments: $14,109
Family Medicine $14,109
Dr. David Boaz, M.d, M.D
Family Medicine — Payments: $13,802
Family Medicine $13,802
Dr. Satishkumar Ganjam, Md, MD
Family Medicine — Payments: $12,813
Family Medicine $12,813
David Hall, M.d, M.D
Family Medicine — Payments: $12,640
Family Medicine $12,640
Terence Moraczewski, M.d, M.D
Family Medicine — Payments: $12,451
Family Medicine $12,451